To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol

NCT01478490 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Mirabegron
Healthy Subjects

Interventions

DRUG: mirabegron
DRUG: metoprolol

Sponsor

Astellas Pharma Inc